Your search returned 13 results.

  • CCyberKnife®
  • TTomoTherapy®
  • AAccuray
  • Prostate Advances in Comparative Evidence (PACE)

    This study is an international multicenter randomized study of organ confined low and intermediate risk prostate cancer and is composed of two parallel randomization schemes based on applicability of surgery as a treatment for the patient. Patients for whom surgery is a consideration are randomized to either laparoscopic or da Vinci prostatectomy or CyberKnife prostate SBRT(also known as CyberKnife radiosurgery). Patients for whom surgery is not a consideration are randomized to either conventionally fractionated radiation therapy or CyberKnife prostate SBRT. Efficacy, toxicity and quality of life outcomes will be compared across the pairs in each randomization.


This section provides CyberKnife and TomoTherapy case studies, created by Accuray in collaboration with our centers, showcasing positive outcomes. Individual treatment results may vary. Please consult a physician to discuss individual cases, including eligibility for treatment with Accuray devices.

This section also provides a selected list of publications supporting the use and efficacy of the CyberKnife and TomoTherapy Systems and is not inclusive of all available publications.

For access to a more comprehensive listing of publications related to CyberKnife and TomoTherapy Systems, visit